Citation: | YANG Le, HU Fangyong. Efficacy of local application of tranexamic acid in total hip arthroplasty of femoral neck fracture[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 29-32,36. DOI: 10.7619/jcmp.202020008 |
National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance[M]. The Management of Hip Fracture in Adults[M]. London: Royal College of Physicians(UK)National Clinical Guideline Centre, 2011: 126-135.
|
SLOVER J, LAVERY J A, SCHWARZKOPF R, et al. Incidence and Risk Factors for Blood Transfusion in Total Joint Arthroplasty: Analysis of a Statewide Database[J]. J Arthroplasty, 2017, 32(9): 2684-2687.
|
SHOKOOHI A, STANWORTH S, MISTRY D, et al. The risks of red cell transfusion for hip fracture surgery in the elderly[J]. Vox Sang, 2012, 103(3): 223-230.
|
SUN X, DONG Q, ZHANG Y G. Intravenous versus topical tranexamic acid in primary total hip replacement: A systemic review and meta-analysis[J]. Int J Surg, 2016, 32: 10-18.
|
YAMAGUCHI A, GOTO K, KAWAI T, et al. Dose optimization of topical tranexamic acid for primary total hip arthroplasty: a prospective cohort study[J]. J Orthop Sci, 2019, 24(2): 275-279.
|
张银光, 戚浩天. 外展嵌插型股骨颈骨折的分型及治疗进展[J]. 武警医学, 2018, 29(10): 925-928
, 934.
|
ZHANG B F, WANG P F, HUANG H, et al. Interventions for treating displaced intracapsular femoral neck fractures in the elderly: a Bayesian network meta-analysis of randomized controlled trials[J]. Sci Rep, 2017, 7: 13103.
|
KIM J L, PARK J H, HAN S B, et al. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis[J]. J Arthroplast, 2017, 32(1): 320-325.
|
WILSON D, COOKE E A, MCNALLY M A, et al. Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture[J]. Injury, 2001, 32(10): 765-770.
|
SONG K, YAO Y, RONG Z, et al. The preoperative incidence of deep vein thrombosis(DVT)and its correlation with postoperative DVT in patients undergoing elective surgery for femoral neck fractures[J]. Arch Orthop Trauma Surg, 2016, 136(10): 1459-1464.
|
TERAO M, OZAKI T, SATO T. Diagnosis of deep vein thrombosis after operation for fracture of the proximal femur: comparative study of ultrasonography and venography[J]. J Orthop Sci, 2006, 11(2): 146-153.
|
马金辉, 孙伟, 高福强, 等. 关节腔注射氨甲环酸单侧全膝关节置换者的失血量及肢体周径变化: 随机对照[J]. 中国组织工程研究, 2014, 18(35): 5577-5582.
|
STOICEA N, MORAN K, MAHMOUD A R, et al. Tranexamic acid use during total hip arthroplasty: a single center retrospective analysis[J]. Medicine(Madr), 2018, 97(21): e10720.
|
NISHIHARA S, HAMADA M. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis[J]. Bone Jo J, 2015, 97-B(4): 458-462.
|
MYERS S P, KUTCHER M E, ROSENGART M R, et al. Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism[J]. J Trauma Acute Care Surg, 2019, 86(1): 20-27.
|
LEE S Y, CHONG S, BALASUBRAMANIAN D, et al. What is the ideal route of administration of tranexamic acid in TKA A randomized controlled trial[J]. Clin Orthop Relat Res, 2017, 475(8): 1987-1996.
|
GOMEZ-BARRENA E, ORTEGA-ANDREU M, PADILLA-EGUILUZ N G, et al. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial[J]. J Bone Joint Surg Am, 2014, 96(23): 1937-1944.
|
CHEN T P, CHEN Y M, JIAO J B, et al. Comparison of the effectiveness and safety of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials[J]. J Orthop Surg Res, 2017, 12(1): 11.
|
PARKER J D, LIM K S, KIESER D C, et al. Is tranexamic acid toxic to articular cartilage when administered topically[J]. Bone Jo J, 2018, 100-B(3): 404-412.
|